Volume 80, Issue 9, (November 2011)

Slides:



Advertisements
Similar presentations
Date of download: 6/23/2016 Copyright © The American College of Cardiology. All rights reserved. From: Outcomes Associated With Microalbuminuria: Effect.
Advertisements

Long-term kidney outcomes among users of proton pump inhibitors without intervening acute kidney injury  Yan Xie, Benjamin Bowe, Tingting Li, Hong Xian,
Improved prognosis of diabetic nephropathy in type 1 diabetes
Copyright © 2011 American Medical Association. All rights reserved.
Chronic Kidney Disease in Diabetes
Volume 80, Issue 1, Pages (July 2011)
Volume 80, Issue 1, Pages (July 2011)
Long-term kidney outcomes among users of proton pump inhibitors without intervening acute kidney injury  Yan Xie, Benjamin Bowe, Tingting Li, Hong Xian,
Chapter 1: Definition and classification of CKD
Frederik Persson, Peter Rossing  Kidney International Supplements 
Simon Sawhney, Simon D. Fraser  Advances in Chronic Kidney Disease 
Practical Approach to Detection and Management of Chronic Kidney Disease for the Primary Care Clinician  Joseph A. Vassalotti, MD, Robert Centor, MD,
Propofol-related green urine
Section 2: AKI Definition
Kidney International Supplements 
Blaithin A. McMahon, Patrick Thomas Murray  Kidney International 
Summary of Recommendation Statements
Volume 79, Issue 12, Pages (June 2011)
Volume 92, Issue 2, Pages (August 2017)
Intermediate and Long-term Outcomes of Survivors of Acute Kidney Injury Episodes: A Large Population-Based Cohort Study  Simon Sawhney, MBChB, Angharad.
Simon Sawhney, Simon D. Fraser  Advances in Chronic Kidney Disease 
Y. Wang, X. Chen, Y. Song, B. Caballero, L.J. Cheskin 
Gudrun Hatlen, Solfrid Romundstad, Stein I. Hallan 
Chronic Kidney Disease in Diabetes
Prehypertension and chronic kidney disease: the ox or the plow?
The urinary metabolome of chronic kidney disease
Corrections to "Estimating the glomerular filtration rate from serum creatinine is better than from cystatin C for evaluating risk factors associated.
Volume 80, Issue 1, Pages (July 2011)
John P. Middleton, Patrick H. Pun  Kidney International 
Susumu Takahashi, Kazuyoshi Okada, Mitsuru Yanai  Kidney International 
Chapter 5: Referral to specialists and models of care
Volume 86, Issue 4, Pages (October 2014)
Your Kidneys May Outlive You
Volume 72, Issue 10, Pages (November 2007)
Volume 92, Issue 1, Pages (July 2017)
Volume 79, Issue 12, Pages (June 2011)
Volume 75, Issue 10, Pages (May 2009)
Steven G. Coca, Swathi Singanamala, Chirag R. Parikh 
Albuminuria as a predictor of cardiovascular and renal outcomes in people with known atherosclerotic cardiovascular disease  Johannes F.E. Mann, Qi-Long.
Volume 84, Issue 5, Pages (November 2013)
U-shaped effect of eGFR and mortality
Volume 83, Issue 4, Pages (April 2013)
by Simon DS Fraser, Paul J Roderick, and Maarten W Taal
Volume 81, Issue 6, Pages (March 2012)
Tilman B. Drüeke, Ziad A. Massy  Kidney International 
Volume 73, Issue 5, Pages (March 2008)
Methods for guideline development
Volume 87, Issue 1, Pages (January 2015)
Volume 76, Issue 8, Pages (October 2009)
Volume 78, Issue 5, Pages (September 2010)
Improved prognosis of diabetic nephropathy in type 1 diabetes
Volume 85, Issue 5, Pages (May 2014)
Volume 80, Issue 12, Pages (December 2011)
Volume 60, Issue 1, Pages (July 2001)
Volume 76, Issue 6, Pages (September 2009)
Blood lead and chronic kidney disease in the general United States population: Results from NHANES III  Paul Muntner, Jiang He, Suma Vupputuri, Josef.
The Danish Renal Biopsy Register
Volume 80, Issue 10, Pages (November 2011)
Volume 81, Issue 7, Pages (April 2012)
Cardiovascular risk in chronic kidney disease
Adiponectin: good, bad, or just plain ugly?
Volume 81, Issue 8, Pages (April 2012)
In chronic kidney disease staging the use of the chronicity criterion affects prognosis and the rate of progression  B.O. Eriksen, O.C. Ingebretsen  Kidney.
Volume 83, Issue 5, Pages (May 2013)
Volume 80, Issue 9, Pages (November 2011)
Friends, social networks, and progressive chronic kidney disease
Volume 78, Issue 5, Pages (September 2010)
Sugar-sweetened beverages and chronic disease
Volume 86, Issue 2, Pages (August 2014)
Diagnostic criteria for AKI
Presentation transcript:

Volume 80, Issue 9, (November 2011) Corrections to "The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report"    Kidney International  Volume 80, Issue 9, (November 2011) DOI: 10.1038/ki.2011.310 Copyright © 2011 International Society of Nephrology Terms and Conditions

Figure 5 Summary of categorical meta-analysis (adjusted relative risk (RR)) for general population cohorts with albumin-tocreatinine ratio (ACR). Mortality is reported for general population cohorts assessing albuminuria as urine ACR. Kidney outcomes are reported for general population cohorts assessing albuminuria as either urine ACR or dipstick. Estimated glomerular filtration rate (eGFR) and albuminuria are expressed as categorical variables. All results are adjusted for covariates and compared with the reference cell (Ref). Each cell represents a pooled relative risk from a meta-analysis; bold numbers indicate statistical significance at P<0.05. Incidence rates per 1000 person-years for the reference cells are 7.0 for all-cause mortality, 4.5 for cardiovascular disease mortality, 0.04 for kidney failure, 0.98 for acute kidney injury (AKI), and 2.02 for kidney disease progression. Absolute risk can be computed by multiplying the relative risks in each cell by the incidence rate in the reference cell. Colors reflect the ranking of adjusted relative risk. The point estimates for each cell were ranked from 1 to 28 (the lowest RR having rank number 1, and the highest number 28). The categories with rank numbers 1–8 are green, rank numbers 9–14 are yellow, the rank numbers 15–21 are orange, and the rank numbers 22–28 are colored red. (For the outcome of kidney disease progression, two cells with RRo1.0 are also green, leaving fewer cells as orange.) Kidney International 2011 80, DOI: (10.1038/ki.2011.310) Copyright © 2011 International Society of Nephrology Terms and Conditions